Amadeus Capital Partners is an investor backing trailblazers solving hard problems across intelligence, human, and planet technology areas from seed to growth stages.
Amadeus Capital Partners led the Seed round, with backing from Ahren Innovation Capital, IQ Capital, Cambridge Enterprise, Martlet Capital, and Seraphim Capital, to fund new labs and recruitment.
"Our aim is to enable the potential of quantum mechanics using quantum photonics hardware. This funding will allow us to do just that – a world-class multidisciplinary team and our new laboratories will give Nu Quantum the ability to deliver meaningful demonstrations of our technology into the hands of customers and partners for the first time."
Draper Esprit led the Series C financing, with continued backing from Amadeus Capital Partners, BlackFin Tech, and Passion Capital.
"We have been very busy in the two years since our last funding round in 2018. Our approach to tackling fraud and risk for enterprise-scale businesses has resonated with the market and we’ve grown our client base rapidly"
The funding round was led by Octopus Ventures and MMC Ventures with participation from Amadeus Capital Partners and Toyota AI Ventures.
"Even before the crisis, SLAMcore was engaged in many conversations with companies – big and small – who needed a better way to solve spatial intelligence issues in robotics. Especially across sectors such as drones, robots, and AR/VR, the coronavirus pandemic has lit the touch-paper and we are primed to meet exploding demand. In the past few weeks alone, we have seen a huge spike in enquiries as robotics companies want fast solutions to get their robots to market sooner."
The investment round was led by Praetura Capital with backing from Boundary Capital Partners and other investors.
"The UK alone spends £3.1bn on treating chronic wounds each year, while the US spends $50bn. Add to this the significant escalation in costs, not to mention the considerable distress to patients and families if the only course of treatment for non-healing wounds is amputation. It’s clear that there’s a real need for innovation in this area."
